Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epirubicin and long-term heart failure risk in breast cancer survivors.

Literature DB >> 29972283

Epirubicin and long-term heart failure risk in breast cancer survivors.

Syed S Mahmood¹, Ravi B Patel², Javed Butler³, Muthiah Vaduganathan⁴.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2018 PMID： 29972283 PMCID： PMC6179931 DOI： 10.1002/ejhf.1215

Source DB: PubMed Journal: Eur J Heart Fail ISSN： 1388-9842 Impact factor: 15.534

× No keyword cloud information.

14 in total

1. Cardiovascular risk assessment in oncological clinical trials: is there a role for centralized events adjudication?

Authors: Muthiah Vaduganathan; Vinay Prasad
Journal: Eur J Heart Fail Date: 2015-12-13 Impact factor: 15.534

2. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.

Authors: Husam Abdel-Qadir; Peter C Austin; Douglas S Lee; Eitan Amir; Jack V Tu; Paaladinesh Thavendiranathan; Kinwah Fung; Geoffrey M Anderson
Journal: JAMA Cardiol Date: 2017-01-01 Impact factor: 14.676

Review 3. Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?

Authors: Bennett E Levis; Phillip F Binkley; Charles L Shapiro
Journal: Lancet Oncol Date: 2017-07-26 Impact factor: 41.316

Review 4. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Authors: Jose Luis Zamorano; Patrizio Lancellotti; Daniel Rodriguez Muñoz; Victor Aboyans; Riccardo Asteggiano; Maurizio Galderisi; Gilbert Habib; Daniel J Lenihan; Gregory Y H Lip; Alexander R Lyon; Teresa Lopez Fernandez; Dania Mohty; Massimo F Piepoli; Juan Tamargo; Adam Torbicki; Thomas M Suter; Jose Luis Zamorano; Victor Aboyans; Stephan Achenbach; Stefan Agewall; Lina Badimon; Gonzalo Barón-Esquivias; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Scipione Carerj; Veronica Dean; Çetin Erol; Donna Fitzsimons; Oliver Gaemperli; Paulus Kirchhof; Philippe Kolh; Patrizio Lancellotti; Gregory Y H Lip; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Marco Roffi; Adam Torbicki; António Vaz Carneiro; Stephan Windecker
Journal: Eur J Heart Fail Date: 2016-08-27 Impact factor: 15.534

5. Improved outcome from substituting methotrexate with epirubicin: results from a randomised comparison of CMF versus CEF in patients with primary breast cancer.

Authors: Bent Ejlertsen; Henning T Mouridsen; Maj-Britt Jensen; Jørn Andersen; Søren Cold; Per Edlund; Marianne Ewertz; Brita B Jensen; Claus Kamby; Bo Nordenskjold; Jonas Bergh
Journal: Eur J Cancer Date: 2007-02-16 Impact factor: 9.162

Epirubicin and long-term heart failure risk in breast cancer survivors.

1. Cardiovascular risk assessment in oncological clinical trials: is there a role for centralized events adjudication?

2. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.

Review 3. Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?

Review 4. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

5. Improved outcome from substituting methotrexate with epirubicin: results from a randomised comparison of CMF versus CEF in patients with primary breast cancer.

6. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.

7. Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer.

8. Accuracy of a heart failure diagnosis in administrative registers.

9. Cancer treatment and survivorship statistics, 2016.

Review 10. Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis.

1. The Predictive Value of 2D Myocardial Strain for Epirubicin-Induced Cardiotoxicity.